Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acute Febrile Encephalopathy (Phase 3)
Autism Spectrum Disorder (Phase 2)
Cerebellar Diseases (Phase 3)
Diffuse Cerebral Sclerosis of Schilder (Phase 2/Phase 3)
Drug Resistant Epilepsy (Phase 2/Phase 3)
Friedreich Ataxia (Phase 2/Phase 3)
Genetic Diseases, Inborn (Phase 2)
Hearing Loss, Noise-Induced (Phase 2)
Hematopoiesis (Phase 2)
Leigh Disease (Phase 2/Phase 3)
Methylmalonic Acid (Phase 2)
Mitochondrial Diseases (Phase 2/Phase 3)
Muscular Diseases (Phase 2)
Neurology (Phase 2)
Parkinson Disease (Phase 2)
Retinal Diseases (Phase 2)
Rett Syndrome (Phase 2)
Tourette Syndrome (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue